Malaria Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030

Malaria Vaccine Trends and Forecast

The future of the global malaria vaccine market looks promising with opportunities in the hospital, specialty clinic, and homecare markets. The global malaria vaccine market is expected to reach an estimated $6.9 billion by 2030 with a CAGR of 18.6% from 2024 to 2030. The major drivers for this market are growing demand for malaria vaccines, emergence of pre-erythrocytic vaccines, and rising preference for vaccine delivery platforms.

A more than 150-page report is developed to help in your business decisions.

Malaria Vaccine by Segment

The study includes a forecast for the global malaria vaccine by type, agent, end use, and region.

Malaria Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Pre-Erythrocytic
• Erythrocytic
• Multi-Antigen
• Others

Malaria Vaccine Market by Agent [Shipment Analysis by Value from 2018 to 2030]:

• Plasmodium Falciparum
• Plasmodium Vivax
• Anopheles Species

Malaria Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Specialty Clinics
• Homecare
• Others

Malaria Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Malaria Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies malaria vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the malaria vaccine companies profiled in this report include-

• Actiza Pharmaceutical
• AdvaCare Pharma
• Ipca Laboratories
• Bliss GVS Pharma
• GeoVax
• Sumaya Biotech
• VLP Therapeutics
• OSIVAX
• AJANTA PHARMA
• Strides Pharma Science

Malaria Vaccine Market Insights

Lucintel forecasts that pre-erythrocytic is expected to witness highest growth over the forecast period.

Within this market, hospital is expected to witness highest growth over the forecast period.

North America will remain the largest region due to existence of robust healthcare infrastructure, high investment in vaccines research and development, and presence of key manufacturers in the region.

Features of the Global Malaria Vaccine Market

Market Size Estimates: Malaria vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Malaria vaccine market size by type, agent, end use, and region in terms of value ($B).

Regional Analysis: Malaria vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, agents, end uses, and regions for the malaria vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the malaria vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the malaria vaccine market size?

Answer: The global malaria vaccine market is expected to reach an estimated $6.9 billion by 2030.

Q.2 What is the growth forecast for malaria vaccine market?

Answer: The global malaria vaccine market is expected to grow with a CAGR of 18.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the malaria vaccine market?

Answer: The major drivers for this market are growing demand for malaria vaccines, emergence of pre-erythrocytic vaccines, and rising preference for vaccine delivery platforms.

Q4. What are the major segments for malaria vaccine market?

Answer: The future of the malaria vaccine market looks promising with opportunities in the hospital, specialty clinic, and homecare markets.

Q5. Who are the key malaria vaccine market companies?

Answer: Some of the key malaria vaccine companies are as follows:

• Actiza Pharmaceutical
• AdvaCare Pharma
• Ipca Laboratories
• Bliss GVS Pharma
• GeoVax
• Sumaya Biotech
• VLP Therapeutics
• OSIVAX
• AJANTA PHARMA
• Strides Pharma Science

Q6. Which malaria vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that pre-erythrocytic is expected to witness highest growth over the forecast period.

Q7. In malaria vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to existence of robust healthcare infrastructure, high investment in vaccines research and development, and presence of key manufacturers in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the malaria vaccine market by type (pre-erythrocytic, erythrocytic, multi-antigen, and others), agent (plasmodium falciparum, plasmodium vivax, and anopheles species), end use (hospitals, specialty clinics, homecare, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?